One day it might be feasible to treat glaucoma by putting on a special set of glasses outfitted with an electromagnetic coil. These glasses, are presently being tested. This device could be able to treat glaucoma without eyedrops, according to a scientist who is researching the same.
In glaucoma, liquid develops in the front part of the eye. The extra liquid causes raised pressure in the eye and this raised pressure can harm the optic nerve. Without treatment, glaucoma can lead to irreversible loss of sight, which is why glaucoma is of such serious concern. Therapy for glaucoma often involves eyedrops to be periodically administered in the eyes, which can produce adverse effects. As well as many older patients have trouble remembering when to put in their eyedrops. “We require a non-invasive, reliable treatment for glaucoma that fixes these concerns, in other words is easy to use and without any side effects and therefore help a number of these patients,” the scientist stated.
The new glasses contain a steel coil that generates a magnetic field and produces a current. The current circulates with the ciliary muscle mass – a ring of muscle within the middle layer of the eye – and electrically charges the location where fluid leaves the eye. The treatment allows the natural water drainage path to work more successfully. This lowers pressure in the eye.
The researchers also are testing the glasses coupled with a contact lens that contains a trace of gold. The glasses transmit the electromagnetic current to the eye through the gold (which is a metal and therefore a good conductor) in the contact lens. Since older individuals are commonly uncomfortable using contact lenses, the scientists manufactured glasses that can be made use of without contacts.
The researchers wish to create a device that will appear like regular spectacle frames. The treatment coil would remain in the frame bordering the lens.
“Like the new glasses, glaucoma medicines also work by stimulating muscle mass function in the eye, so what the coil does is replace the eye drops” the scientist stated. “Instead of using drops, we’re making use of low-voltage, risk-free electromagnetic current in the glasses that reaches the eye.”
He said early research studies, which are still continuing, seem to recommend that the treatment appears to be safe. “Patients do not experience any kind of discomfort or pain and we have not seen any type of side effects so far, so this may prove to be a very effective and preferred treatment for glaucoma.”
Animal studies revealed these glasses reduced intraocular eye stress swiftly – within 10 to 15 mins. Human researches are beginning in the USA, Canada as well as Spain. Another eye doctor was optimistic regarding the opportunities presented by this device. “If scientific tests verify this therapy to be safe and also effective, it can alter the lives of many people, even in various stages of glaucoma treatment. The thought of having a non-surgical and also a non-pharmaceutical technique to lower IOP (intraocular pressure) is very exciting. There is still much to find out, however, it would definitely assist a great number of people.”
If the therapy works, it could prevent additional loss of vision in clients with glaucoma. The scientist hopes the treatment could be made use of in a variety of people, who have the disease. People with early glaucoma who don’t want to put in eyedrops every day can benefit as much as those that already make use of medication and also want to lower the number of drops required to be put in each day. It may also serve for patients with advanced glaucoma who have had surgical treatment, by providing them an alternative therapy.
“We are currently researching lots of concerns, including how long people need to wear the glasses, what dosage of current is needed, as well as for how long the impact of the glasses lasts, after an individual takes them off. Once these researches throw up the results, the treatment is then ready for clinical application for the very many patients of glaucoma,” the scientist claimed. “Throughout the following year, we’ll start to see how reliable the treatment is, as well as obtain a much better idea of when it could come to be readily available.”